SAR245408 is primarily used in the field of medical research, particularly in oncology. It functions as an inhibitor targeting specific pathways involved in cancer cell growth and survival. Researchers utilize this compound to study its effects on tumors and to explore its potential as a therapeutic agent in treating various types of cancers. Its application extends to preclinical studies where it helps in understanding the mechanisms of cancer progression and in evaluating the efficacy of targeted therapies. Additionally, SAR245408 is employed in combination studies with other anticancer agents to assess synergistic effects and improve treatment outcomes. This makes it a valuable tool in the development of novel cancer treatments.